HomeCompareNVIVQ vs NNN

NVIVQ vs NNN: Dividend Comparison 2026

NVIVQ yields 540.54% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVIVQ wins by $112786.20M in total portfolio value
10 years
NVIVQ
NVIVQ
● Live price
540.54%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112786.22M
Annual income
$82,692,515,806.61
Full NVIVQ calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — NVIVQ vs NNN

📍 NVIVQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVIVQNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVIVQ + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVIVQ pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVIVQ
Annual income on $10K today (after 15% tax)
$45,945.95/yr
After 10yr DRIP, annual income (after tax)
$70,288,638,435.62/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, NVIVQ beats the other by $70,288,636,206.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVIVQ + NNN for your $10,000?

NVIVQ: 50%NNN: 50%
100% NNN50/50100% NVIVQ
Portfolio after 10yr
$56393.12M
Annual income
$41,346,259,214.65/yr
Blended yield
73.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

NVIVQ
No analyst data
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVIVQ buys
0
NNN buys
2
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$NNN▼ Sell$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$NNN▲ Buy$1,001 - $15,0002025-06-17
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002023-05-25
Ro Khanna🏢 House$NNN▼ Sell$1,001 - $15,0002022-01-20
Zoe Lofgren🏢 House$NNN▲ Buy$1,001 - $15,0002021-09-30
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002020-03-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVIVQNNN
Forward yield540.54%5.66%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$112786.22M$25.5K
Annual income after 10y$82,692,515,806.61$2,622.67
Total dividends collected$110217.05M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NVIVQ vs NNN ($10,000, DRIP)

YearNVIVQ PortfolioNVIVQ Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$64,754$54,054.05$10,735$614.96+$54.0KNVIVQ
2$396,410$327,123.28$11,572$708.43+$384.8KNVIVQ
3$2,295,726$1,871,567.31$12,531$819.53+$2.28MNVIVQ
4$12,586,137$10,129,710.14$13,633$952.29+$12.57MNVIVQ
5$65,369,349$51,902,182.37$14,909$1,111.84+$65.35MNVIVQ
6$321,877,325$251,932,121.38$16,392$1,304.77+$321.86MNVIVQ
7$1,503,762,535$1,159,353,797.14$18,129$1,539.52+$1503.74MNVIVQ
8$6,671,013,644$5,061,987,731.83$20,173$1,827.08+$6670.99MNVIVQ
9$28,124,961,234$20,986,976,635.20$22,597$2,181.81+$28124.94MNVIVQ
10$112,786,224,327$82,692,515,806.61$25,491$2,622.67+$112786.20MNVIVQ

NVIVQ vs NNN: Complete Analysis 2026

NVIVQStock

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Full NVIVQ Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this NVIVQ vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVIVQ vs SCHDNVIVQ vs JEPINVIVQ vs ONVIVQ vs KONVIVQ vs MAINNVIVQ vs ADCNVIVQ vs EPRTNVIVQ vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.